These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36094811)

  • 1. Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging.
    Lipka A; Niess E; Dal-Bianco A; Hangel GJ; Rommer PS; Strasser B; Motyka S; Hingerl L; Berger T; Hnilicová P; Kantorová E; Leutmezer F; Kurča E; Gruber S; Trattnig S; Bogner W
    Invest Radiol; 2023 Feb; 58(2):156-165. PubMed ID: 36094811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Insights into Iron Deposition in Relapsing-Remitting Multiple Sclerosis via 7 T Magnetic Resonance Spectroscopic Imaging.
    Lipka A; Bogner W; Dal-Bianco A; Hangel GJ; Rommer PS; Strasser B; Motyka S; Hingerl L; Berger T; Leutmezer F; Gruber S; Trattnig S; Niess E
    Neuroimage Clin; 2023; 40():103524. PubMed ID: 37839194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.
    Chard DT; Griffin CM; McLean MA; Kapeller P; Kapoor R; Thompson AJ; Miller DH
    Brain; 2002 Oct; 125(Pt 10):2342-52. PubMed ID: 12244090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.
    Heckova E; Dal-Bianco A; Strasser B; Hangel GJ; Lipka A; Motyka S; Hingerl L; Rommer PS; Berger T; Hnilicová P; Kantorová E; Leutmezer F; Kurča E; Gruber S; Trattnig S; Bogner W
    Radiology; 2022 Apr; 303(1):141-150. PubMed ID: 34981978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.
    Klauser AM; Wiebenga OT; Eijlers AJ; Schoonheim MM; Uitdehaag BM; Barkhof F; Pouwels PJ; Geurts JJ
    Mult Scler; 2018 Apr; 24(4):491-500. PubMed ID: 28406063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance fingerprinting in multiple sclerosis.
    Ontaneda D; Gulani V; Deshmane A; Shah A; Guruprakash DK; Jiang Y; Ma D; Fisher E; Rudick RA; Raza P; Kilbane M; Cohen JA; Sakaie K; Lowe MJ; Griswold MA; Nakamura K
    Mult Scler Relat Disord; 2023 Nov; 79():105024. PubMed ID: 37783196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spiral MRSI and tissue segmentation of normal-appearing white matter and white matter lesions in relapsing remitting multiple sclerosis patients
    Al-Iedani O; Ribbons K; Gholizadeh N; Lechner-Scott J; Quadrelli S; Lea R; Andronesi O; Ramadan S
    Magn Reson Imaging; 2020 Dec; 74():21-30. PubMed ID: 32898652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.
    Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C
    Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
    Tiberio M; Chard DT; Altmann DR; Davies G; Griffin CM; McLean MA; Rashid W; Sastre-Garriga J; Thompson AJ; Miller DH
    J Neurol; 2006 Feb; 253(2):224-30. PubMed ID: 16307201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
    Khormi I; Al-Iedani O; Casagranda S; Papageorgakis C; Alshehri A; Lea R; Liebig P; Ramadan S; Lechner-Scott J
    Magn Reson Imaging; 2023 Oct; 102():212-221. PubMed ID: 37321380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.
    Inglese M; Madelin G; Oesingmann N; Babb JS; Wu W; Stoeckel B; Herbert J; Johnson G
    Brain; 2010 Mar; 133(Pt 3):847-57. PubMed ID: 20110245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
    John NA; Solanky BS; De Angelis F; Parker RA; Weir CJ; Stutters J; Carrasco FP; Schneider T; Doshi A; Calvi A; Williams T; Plantone D; Monteverdi A; MacManus D; Marshall I; Barkhof F; Gandini Wheeler-Kingshott CAM; Chataway J;
    J Magn Reson Imaging; 2024 Jun; 59(6):2192-2201. PubMed ID: 37787109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid and White Matter Suppression: New Sensitive 3 T Magnetic Resonance Imaging Contrasts for Cortical Lesion Detection in Multiple Sclerosis.
    Müller J; La Rosa F; Beaumont J; Tsagkas C; Rahmanzadeh R; Weigel M; Bach Cuadra M; Gambarota G; Granziera C
    Invest Radiol; 2022 Sep; 57(9):592-600. PubMed ID: 35510874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
    Dadar M; Mahmoud S; Narayanan S; Collins DL; Arnold DL; Maranzano J
    Brain; 2022 Jun; 145(6):2008-2017. PubMed ID: 34927199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.